Biocon Q3 net profit falls 25 per cent; revenue up 36 per cent at Rs ...

Feb 15, 2023  · The company's net R&D investments for the quarter grew by 144% to Rs 337 crore, representing 16% of revenues ex-Syngene. ... Biocon has reported a 25% y-o-y decline …


Install CouponFollow Chrome Extension   CouponFollow Extension

144%
OFF

Biocon Q3 Net Profit Falls 25 Per Cent; Revenue Up 36 Per Cent At Rs ...

2 weeks from now

Feb 15, 2023  · The company's net R&D investments for the quarter grew by 144% to Rs 337 crore, representing 16% of revenues ex-Syngene. ... Biocon has reported a 25% y-o-y decline …

newindianexpress.com

7%
OFF

Biocon Q3FY25 Revenue At Rs 3,856 Cr, Up 7%# EBITDA At Rs 787 …

2 weeks from now

Jan 30, 2025  · Financial Commentary: Q3FY25. Consolidated Total Revenue for Q3FY25 was at Rs 3,856 crore.Reported 7% YoY growth on a like-for-like basis, after adjusting for Branded …

biocon.com

96%
OFF

Biocon Q3 Results: Profit Plummets 96%; Misses Estimates

2 weeks from now

Jan 30, 2025  · Biocon Ltd.'s Q3FY25 consolidated net profit plummeted 96% to Rs 25 crore, falling short of analysts' estimates. Revenue declined 3.4% to Rs 3,821 crore. Biocon Ltd.'s …

ndtvprofit.com

36%
OFF

Biocon Q3FY23 Earnings: Revenue Up 36%, PAT Falls 25% YoY

2 weeks from now

Feb 14, 2023  · Biocon Q3FY23 Earnings: Revenue up 36%, PAT falls 25% YoY. With a market capitalization of ₹ 28,202.09 Cr, Biocon Ltd. is a large-cap company that engages in the …

livemint.com

41%
OFF

Biocon Reports Dip In PAT 25 Percent Yoy; Revenue Up 36 Percent …

2 weeks from now

Feb 14, 2023  · On Tuesday, the shares of Biocon Limited closed on the NSE at Rs. 234.35 apiece, down by 1.41% from the previous close of Rs.237.70. Also Read Biocon’s net profit …

financialexpress.com

96%
OFF

Biocon's Profit Struggles Continue In Q3; Net Profit Plunges 96%

2 weeks from now

Jan 31, 2025  · Biocon Q3 Profit Plunge: On a year-on-year basis, the company’s total revenue has contracted by 15 per cent to ₹3,856 crore from ₹4,519 crore. However, on a like-for-like …

indiatimes.com

4%
OFF

Here's Why Biocon Share Price Gained 4% Despite Fall In Profits In Q3

2 weeks from now

Jan 31, 2025  · Biocon share price gained 3.82 per cent at Rs 370.80 a piece on the BSE in Friday’s intraday trade after the company’s earnings for the third quarter of financial year 2024 …

business-standard.com

16%
OFF

Biocon Q3 Results: All Business Segments Grow; EBITDA Up 16%, …

2 weeks from now

Jan 30, 2025  · Also read: GAIL Q3 Results: Stock rises despite missing estimates on EBITDA, margin front Last year’s net profit was significantly boosted by the gains from the BFI …

cnbctv18.com

96%
OFF

Biocon Q3 Results: PAT Plunges 96% To ₹25 Cr; Revenue Up 7%

2 weeks from now

Jan 30, 2025  · Net R&D investments for the quarter stood at ₹199 crore, accounting for 7 per cent of revenue (excluding Syngene). EBITDA for the quarter stood at ₹787 crore, up 16 per cent …

thehindubusinessline.com

4%
OFF

Biocon Ltd's Q3FY25 Quarter Results - Kotaksecurities.com

2 weeks from now

Jan 31, 2025  · Biocon Ltd reported a 6.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a …

kotaksecurities.com

50%
OFF

Biocon Q3FY24 Results: Net Profit At Rs 660 Crore, Revenue Up 50%

2 weeks from now

Feb 8, 2024  · Bengaluru-based biopharma firm Biocon reported a net profit before exceptional items at Rs 660 crore for the third quarter of the financial year 2023-24 as against a net loss of …

business-standard.com

50%
OFF

Biocon Q3FY24 Revenue At Rs 4,519 Cr, Up 50%; Biosimilars Up …

2 weeks from now

Feb 8, 2024  · Net R&D investments for the quarter were Rs 329 crore, representing 11% of revenue ex-Syngene. Core EBITDA at Rs 983 crore, represents core operating margins of …

biocon.com

36%
OFF

Biocon Reports Net Loss Of Rs 42 Cr, Sales Up By 36% YoY In …

2 weeks from now

Feb 14, 2023  · The company's generics grew by 18 per cent year on year to Rs 718 crores, while its biosimilar business stood at Rs 1,507 crores in the December quarter, up by 54 per cent …

businessworld.in

33%
OFF

Biocon Q3 Results: Firm Reports Surprise Net Loss Of Rs 41.8 Crore ...

2 weeks from now

Feb 14, 2023  · CNBC-TV18 Polls had predicted revenue of Rs 2,677.1 crore for the quarter under review. Also Read: Apollo Hospitals Q3 net profit drops 33%, revenue up 17% At the operating …

cnbctv18.com

5%
OFF

Biocon Buys Back An Investor Stake In Biologics Unit, Posts Rs 25 …

2 weeks from now

Jan 30, 2025  · Biocon's board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected to complete by February 1, …

indiatimes.com

3%
OFF

Asian Paints Q3FY25 Results: Net Profit Falls 23.3% Rs 1,110 Crore

2 weeks from now

3 days ago  · Asian Paints saw its net profit decline by 23.3 per cent in the quarter ended December. The country’s largest paint maker reported a profit of Rs 1,110 crore, while its …

business-standard.com

36%
OFF

Biocon Q3FY23 Revenue At Rs 3,020 Cr, Up 36%; Biosimilars Up …

2 weeks from now

Mar 9, 2023  · EBITDA at Rs 723 Cr, Up 35%; Core EBITDA at Rs 1,069 Cr, Up 49%; Net Profit (excluding exceptional items) at Rs 140 Cr Bengaluru, Karnataka, India: February 14, 2023: …

bioconbiologics.com

FAQs about Biocon Q3 net profit falls 25 per cent; revenue up 36 per cent at Rs ... Coupon?

What was Biocon's net profit in Q3 fy25?

Biocon reported a net profit of Rs 25 crore in Q3 FY25, driven by growth in biosimilars and research services. The company's total income stood at Rs 3,821 crore. Read more. New Delhi, Jan 30 (PTI) Biotech firm Biocon on Thursday reported a net profit of Rs 25 crore for the October-December quarter of 2024-25. ...

How did Biocon perform in Q3 fy25?

Adjusting for these factors, Biocon’s Q3 FY25 revenue saw a 10 per cent year-on-year growth. The company’s net research and development investments for the quarter stood at Rs 199 crore, representing 7 per cent of revenue excluding Syngene. Moreover, Biocon’s biosimilars segment grew 14 per cent Y-o-Y to Rs 2,289 crore. ...

How did Biocon perform in the third quarter 2022?

Biotechnology major Biocon on Tuesday reported a net loss of Rs 41.8 crore for the third quarter that ended December 31, 2022. The company reported a one-time loss of Rs 271.4 crore, it said in an exchange filing. In the corresponding quarter last year, the company posted a net profit of Rs 187.1 crore. ...

Why did Biocon grow 10 per cent sequential revenue?

Siddharth Mittal, chief executive officer and managing director, Biocon, noted, “The 10 per cent sequential revenue growth in the generics business was primarily driven by API sales, supported by an improved performance from generic formulations. We expect to see an improved performance in the quarters ahead.” ...

What caused a decrease in Biocon's profit?

Biocon reported a fall in profit due to dilution of Biocon’s stake in Biocon Biologics and Syngene. Biocon Ltd., with a market capitalization of ₹ 28,202.09 Cr, is a large-cap company that engages in the pharmaceutical industry. ...

What happened to Biocon Ltd shares?

Shares of Biocon Ltd ended at Rs 234.90, down by Rs 2.80, or 1.18 percent on the BSE. Biotechnology major Biocon on Tuesday reported a net loss of Rs 41.8 crore for the third quarter that ended December 31, 2022. The company reported a one-time loss of Rs 271.4 crore, it said in an exchange filing. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension